In vivo regulation mainly involves the transcription from DNA to RNA and the translation process from RNA to protein. Nucleic acid drugs through the siRNA pathway mainly reduce protein expression by inhibiting or degrading mRNA in the body. However, nucleic acid drugs in the form of mRNA can achieve the purpose of treatment by introducing exogenous mRNA to cause protein overexpression.